Evo-devo of child growth III: Premature juvenility as an evolutionary trade-off

Hormone Research in Paediatrics

Volumn 73, Issue 6, 2010, Pages 430-437

  Hochberg, Ze'Ev ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b MEYER CHILDREN S HOSPITAL   (Israel)

Author keywords

Adrenarche; Juvenility; Pubarche

Indexed keywords

INSULIN; PRASTERONE SULFATE;

ADRENARCHE; APPETITE; BODY HEIGHT; BODY SIZE; BODY WEIGHT; BRAIN GROWTH; CHILD DEVELOPMENT; CHILD GROWTH; DIETARY INTAKE; DYSLIPIDEMIA; FERTILITY; GROWTH RATE; HUMAN; HUMAN PYGMY; HYPERANDROGENISM; HYPERINSULINEMIA; JUVENILE; LIFE EXPECTANCY; LIFE HISTORY; LOW BIRTH WEIGHT; NOONAN SYNDROME; OBESITY; OVARY POLYCYSTIC DISEASE; PRADER WILLI SYNDROME; PREMATURE JUVENILITY; PRENATAL GROWTH; PRIORITY JOURNAL; REBOUND; REPRODUCTION; SHORT STATURE; SHORT SURVEY; SILVER RUSSELL SYNDROME; SOCIAL INTERACTION;

ADRENARCHE; BODY HEIGHT; EVOLUTION; GROWTH; HUMANS; MENARCHE; PUBERTY;

EID: 77952294672     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000282109     Document Type: Short Survey

References (70)

1. Hochberg Z: Juvenility in the context of life history theory. Arch Dis Child 2008; 93: 534-539.
2. White S: The child's entry into the age of reason; in Sameroff A, Haith MM (ed): The Five to Seven Year Shift: The Age of Reason and Responsibility. Chicago, University of Chicago Press, 1996, pp 17-32.
3. Hochberg Z: Evo-devo of child growth II: Human life history and transition between its phases. Eur J Endocrinol 2009; 160: 135-141.
4. Bogin B: Evolutionary perspective on human growth. Annu Rev Anthropol 1999; 28: 109-153.
5. Remer T, Manz F: Role of nutritional status in the regulation of adrenarche. J Clin Endocrinol Metab 1999; 84: 3936-3944.
6. Williams SM, Goulding A: Patterns of growth associated with the timing of adiposity rebound. Obesity (Silver Spring) 2009; 17: 335-341.
7. Ellis BJ, Essex MJ: Family environments, adrenarche, and sexual maturation: a longitudinal test of a life history model. Child Dev 2007; 78: 1799-1817.
8. Smith BH, Tompkins RL: Toward a life history of the hominidae. Annu Rev Anthropol 1995; 24: 257-279.
9. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TF 3rd, Herman DH, Clasen LS, Toga AW, Rapoport JL, Thompson PM: Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA 2004; 101: 8174-8179.
10. Paus T: Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci 2005; 9: 60-68.
11. Palmert MR, Hayden DL, Mansfield MJ, Crigler JF Jr, Crowley WF Jr, Chandler DW, Boepple PA: The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. J Clin Endocrinol Metab 2001; 86: 4536-4542.
12. Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK: Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 2000; 85: 4650-4656.
13. Suzuki T, Sasano H, Takeyama J, Kaneko C, Freije WA, Carr BR, Rainey WE: Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies. Clin Endocrinol (Oxf) 2000; 53: 739-747.
14. Chen CC, Parker CR Jr: Adrenal androgens and the immune system. Semin Reprod Med 2004; 22: 369-377.
15. Arquitt AB, Stoecker BJ, Hermann JS, Winterfeldt EA: Dehydroepiandrosterone sulfate, cholesterol, hemoglobin, and anthropometric measures related to growth in male adolescents. J Am Diet Assoc 1991; 91: 575-579.
16. Zemel BS, Katz SH: The contribution of adrenal and gonadal androgens to the growth in height of adolescent males. Am J Phys Anthropol 1986; 71: 459-466.
17. Campbell B: Adrenarche and the evolution of human life history. Am J Hum Biol 2006; 18: 569-589.
18. Rodda C, Jones DA, Round J, Grant DB: Muscle strength in girls with congenital adrenal hyperplasia. Acta Paediatr Scand 1987; 76: 495-499.
19. Ellis KJ: Body composition of a young, multiethnic, male population. Am J Clin Nutr 1997; 66: 1323-1331.
20. Remer T, Manz F: The midgrowth spurt in healthy children is not caused by adrenarche. J Clin Endocrinol Metab 2001; 86: 4183-4186.
21. Van Dop C, Burstein S, Conte FA, Grumbach MM: Isolated gonadotropin deficiency in boys: clinical characteristics and growth. J Pediatr 1987; 111: 684-692.
22. Rolland-Cachera MF, Deheeger M, Maillot M, Bellisle F: Early adiposity rebound: causes and consequences for obesity in children and adults. Int J Obes (Lond) 2006; 30(Suppl 4):S11-S17.
23. Guven A, Cinaz P, Ayvali E: Are growth factors and leptin involved in the pathogenesis of premature adrenarche in girls? J Pediatr Endocrinol Metab 2005; 18: 785-791.
24. Utriainen P, Voutilainen R, Jaaskelainen J: Girls with premature adrenarche have accelerated early childhood growth. J Pediatr 2009; 154: 882-887.
25. Lindgren AC, Barkeling B, Hagg A, Ritzen EM, Marcus C, Rossner S: Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups. J Pediatr 2000; 137: 50-55.
26. Hirsch HJ, Eldar-Geva T, Benarroch F, Rubinstein O, Gross-Tsur V: Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. J Clin Endocrinol Metab 2009; 94: 2262-2268.
27. Unanue N, Bazaes R, Iniguez G, Cortes F, Avila A, Mericq V: Adrenarche in Prader- Willi syndrome appears not related to insulin sensitivity and serum adiponectin. Horm Res 2007; 67: 152-158.
28. Haig D, Wharton R: Prader-Willi syndrome and the evolution of human childhood. Am J Hum Biol 2003; 15: 320-329.
29. Wollmann HA, Kirchner T, Enders H, Preece MA, Ranke MB: Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr 1995; 154: 958-968.
30. Sippell WG, Partsch CJ, Wiedemann HR: Growth, bone maturation and pubertal development in children with the EMG-syndrome. Clin Genet 1989; 35: 20-28.
31. Ranke MB, Heidemann P, Knupfer C, Enders H, Schmaltz AA, Bierich JR: Noonan syndrome: growth and clinical manifestations in 144 cases. Eur J Pediatr 1988; 148: 220-227.
32. Dechert U, Duncan AM, Bastien L, Duff C, Adam M, Jirik FR: Protein-tyrosine phosphatase SH-PTP2 (PTPN11) is localized to 12q24.1-24.3. Hum Genet 1995; 96: 609-615.
33. Witchel SF, Smith R, Tomboc M, Aston CE: Candidate gene analysis in premature pubarche and adolescent hyperandrogenism. Fertil Steril 2001; 75: 724-730.
34. Petry CJ, Ong KK, Michelmore KF, Artigas S, Wingate DL, Balen AH, de Zegher F, Ibanez L, Dunger DB: Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Hum Reprod 2005; 20: 1837- 1843.
35. Ibanez L, Ong KK, Mongan N, Jaaskelainen J, Marcos MV, Hughes IA, De Zegher F, Dunger DB: Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J Clin Endocrinol Metab 2003; 88: 3333-3338.
36. Lappalainen S, Utriainen P, Kuulasmaa T, Voutilainen R, Jaaskelainen J: Androgen receptor gene CAG repeat polymorphism and X-chromosome inactivation in children with premature adrenarche. J Clin Endocrinol Metab 2008; 93: 1304-1309.
37. Ibanez L, Ong K, Potau N, Marcos MV, de Zegher F, Dunger D: Insulin gene variable number of tandem repeat genotype and the low birth weight, precocious pubarche, and hyperinsulinism sequence. J Clin Endocrinol Metab 2001; 86: 5788-5793.
38. Roldan MB, White C, Witchel SF: Association of the GAA1013- 1 GAG polymorphism of the insulin-like growth factor-1 receptor (IGF1R) gene with premature pubarche. Fertil Steril 2007; 88: 410-417.
39. Lappalainen S, Voutilainen R, Utriainen P, Laakso M, Jaaskelainen J: Genetic variation of FTO and TCF7l2 in premature adrenarche. Metabolism 2009; 58: 1263-1269.
40. Ong KK, Potau N, Petry CJ, Jones R, Ness AR, Honour JW, de Zegher F, Ibanez L, Dunger DB: Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. J Clin Endocrinol Metab 2004; 89: 2647-2651.
41. Dahlgren J, Boguszewski M, Rosberg S, Albertsson-Wikland K: Adrenal steroid hormones in short children born small for gestational age. Clin Endocrinol (Oxf) 1998; 49: 353-361.
42. Hokken-Koelega AC: Timing of puberty and fetal growth. Best Pract Res Clin Endocrinol Metab 2002; 16: 65-71.
43. Potau N, Ibanez L, Rique S, Sanchez-Ufarte C, de Zegher F: Pronounced adrenarche and precocious pubarche in boys. Horm Res 1999; 51: 238-241.
44. Ibanez L, Dimartino-Nardi J, Potau N, Saenger P: Premature adrenarche - normal variant or forerunner of adult disease? Endocr Rev 2000; 21: 671-696.
45. Ibanez L, Potau N, Francois I, de Zegher F: Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998; 83: 3558-3562.
46. Ibanez L, Ong K, de Zegher F, Marcos MV, del Rio L, Dunger DB: Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche. Clin Endocrinol (Oxf) 2003; 58: 372-379.
47. Ibanez L, Jimenez R, de Zegher F: Early puberty- menarche after precocious pubarche: relation to prenatal growth. Pediatrics 2006; 117: 117-121. (Pubitemid 46050527)
48. Ibanez L, Lopez-Bermejo A, Diaz M, Marcos MV, de Zegher F: Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche. J Clin Endocrinol Metab 2008; 93: 1841-1845.
49. Franks S, McCarthy MI, Hardy K: Development of polycystic ovary syndrome: Involvement of genetic and environmental factors. Int J Androl 2006; 29: 278-285, discussion 286-290.
50. Banerjee S, Raghavan S, Wasserman EJ, Linder BL, Saenger P, DiMartino-Nardi J: Hormonal findings in African-American and Caribbean Hispanic girls with premature adrenarche: implications for polycystic ovarian syndrome. Pediatrics 1998; 102:E36.
51. Dunaif A, Sorbara L, Delson R, Green G: Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean- Hispanic women. Diabetes 1993; 42: 1462-1468.
52. Shah NA, Antoine HJ, Pall M, Taylor KD, Azziz R, Goodarzi MO: Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93: 1939-1945.
53. Migliano AB, Vinicius L, Lahr MM: Life history trade-offs explain the evolution of human pygmies. Proc Natl Acad Sci USA 2007; 104: 20216-20219.
54. Hochberg Z, Albertsson-Wikland K: Evodevo of infantile and childhood growth. Pediatr Res 2008; 64: 2-7.
55. Cutler GB Jr, Glenn M, Bush M, Hodgen GD, Graham CE, Loriaux DL: Adrenarche: a survey of rodents, domestic animals, and primates. Endocrinology 1978; 103: 2112-2118.
56. Cole TJ, Freeman JV, Preece MA: Body mass index reference curves for the UK, 1990. Arch Dis Child 1995; 73: 25-29.
57. Smith BH: Patterns of dental development in Homo, Australopithecus, Pan, and Gorilla. Am J Phys Anthropol 1994; 94: 307-325.
58. Saunders E: Teeth a test of age. London, Renshaw, 1837.
59. Helm S: Secular trend in tooth eruption: a comparative study of Danish school children of 1913 and 1965. Arch Oral Biol 1969; 14: 1177-1191.
60. Smith TM, Tafforeau P, Reid DJ, Grun R, Eggins S, Boutakiout M, Hublin JJ: From the cover: earliest evidence of modern human life history in North African early Homo sapiens . Proc Natl Acad Sci USA 2007; 104: 6128-6133.
61. Coppa A, Manni F, Stringer C, Vargiu R, Vecchi F: Evidence for new Neanderthal teeth in Tabun cave (Israel) by the application of self-organizing maps (SOMs). J Hum Evol 2007; 52: 601-613.
62. Corbett SJ, McMichael AJ, Prentice AM: Type 2 diabetes, cardiovascular disease, and the evolutionary paradox of the polycystic ovary syndrome: a fertility first hypothesis. Am J Hum Biol 2009; 21: 587-598.
63. Hochberg Z, Etzioni A: Genetic selection in nonclassical adrenal hyperplasia. J Clin Endocrinol Metab 1995; 80: 325-326.
64. van Goozen SH, Matthys W, Cohen-Kettenis PT, Thijssen JH, van Engeland H: Adrenal androgens and aggression in conduct disorder prepubertal boys and normal controls. Biol Psychiatry 1998; 43: 156-158.
65. Dorn LD, Hitt SF, Rotenstein D: Biopsychological and cognitive differences in children with premature vs. on-time adrenarche. Arch Pediatr Adolesc Med 1999; 153: 137-146.
66. Arlt W, Callies F, Allolio B: DHEA replacement in women with adrenal insufficien - cy - pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition. Endocr Res 2000; 26: 505-511.
67. Ibanez L, Virdis R, Potau N, Zampolli M, Ghizzoni L, Albisu MA, Carrascosa A, Bernasconi S, Vicens-Calvet E: Natural history of premature pubarche: an auxological study. J Clin Endocrinol Metab 1992; 74: 254-257.
68. Pere A, Perheentupa J, Peter M, Voutilainen R: Follow up of growth and steroids in premature adrenarche. Eur J Pediatr 1995; 154: 346-352.
69. Gluckman PD, Hanson MA: Evolution, development and timing of puberty. Trends Endocrinol Metab 2006; 17: 7-12.
70. Cronk C, Crocker AC, Pueschel SM, Shea AM, Zackai E, Pickens G, Reed RB: Growth charts for children with down syndrome: 1 month to 18 years of age. Pediatrics 1988; 81: 102-110.